198 related articles for article (PubMed ID: 16393468)
1. Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro.
Shimizu T; Kanai K; Kyo Y; Asano K; Hisamitsu T; Suzaki H
J Pharm Pharmacol; 2006 Jan; 58(1):91-9. PubMed ID: 16393468
[TBL] [Abstract][Full Text] [Related]
2. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
3. Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.
Shimizu T; Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2005 Aug; 2005(3):150-9. PubMed ID: 16106101
[TBL] [Abstract][Full Text] [Related]
4. Suppressive activity of fexofenadine hydrochloride on metalloproteinase production from nasal fibroblasts in vitro.
Asano K; Kanai KI; Suzaki H
Clin Exp Allergy; 2004 Dec; 34(12):1890-8. PubMed ID: 15663564
[TBL] [Abstract][Full Text] [Related]
5. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
6. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
[TBL] [Abstract][Full Text] [Related]
7. Association of a high activity of matrix metalloproteinase-9 to low levels of tissue inhibitors of metalloproteinase-1 and -3 in human hepatitis B-viral hepatoma cells.
Kim JR; Kim CH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2293-306. PubMed ID: 15313474
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
Ding HL; Guo Y; Xu MT; Li HY; Fu ZZ
Chin Med J (Engl); 2007 Nov; 120(21):1886-9. PubMed ID: 18067760
[TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
11. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
12. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinase-2, -9 and their inhibitor-1 in hypertrophic scars].
Xie XF; He LX; Hao XF; Chen B; Jia CY; Sun ZG; Cao YJ; Li DH
Zhonghua Shao Shang Za Zhi; 2007 Dec; 23(6):444-6. PubMed ID: 18457258
[TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
Bernal F; Elias B; Hartung HP; Kieseier BC
Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
[TBL] [Abstract][Full Text] [Related]
15. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia.
Liuzzi GM; Mastroianni CM; Latronico T; Mengoni F; Fasano A; Lichtner M; Vullo V; Riccio P
Brain; 2004 Feb; 127(Pt 2):398-407. PubMed ID: 14662518
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in pigmented villonodular synovitis suggests their potential role for joint destruction.
Uchibori M; Nishida Y; Tabata I; Sugiura H; Nakashima H; Yamada Y; Ishiguro N
J Rheumatol; 2004 Jan; 31(1):110-9. PubMed ID: 14705229
[TBL] [Abstract][Full Text] [Related]
18. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
Anand SP; Selvaraj P
Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Hinz B
J Natl Cancer Inst; 2008 Jan; 100(1):59-69. PubMed ID: 18159069
[TBL] [Abstract][Full Text] [Related]
20. Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro.
Namba M; Asano K; Kanai K; Kyo Y; Watanabe S; Hisamitsu T; Suzaki H
Acta Otolaryngol; 2004 Oct; 124(8):964-9. PubMed ID: 15513534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]